Combined pharmacological preconditioning with a G-protein-coupled receptor agonist, a mitochondrial KATP channel opener and a nitric oxide donor mimics ischaemic preconditioning

Authors: Otani H.1; Okada T.1; Fujiwara H.1; Uchiyama T.1; Sumida T.1; Kido M.1; Imamura H.1

Source: Clinical and Experimental Pharmacology and Physiology, Volume 30, Number 9, September 2003 , pp. 684-693(10)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary

1. Although pharmacological preconditioning (PPC) has emerged as an alternative to ischaemic preconditioning (IPC) in cardioprotection, the efficacy of PPC compared with IPC has not been investigated. Because IPC is mediated by complex signalling cascades arising from multiple triggers, we have hypothesized that combined PPC is necessary to mimic IPC.

2. Isolated and perfused rat hearts underwent IPC by three cycles of 5 min ischaemia and 5 min reperfusion before 30 min global ischaemia followed by 120 min reperfusion. Adenosine (30 µmol/L), diazoxide (50 µmol/L) ands-nitroso-N-acetylpenicillamine (SNAP; 50 µmol/L) were added for 25 min just before (pretreatment modality) or 45 min before (PPC modality) the index ischaemia.

3. Ischaemic preconditioning significantly improved isovolumic left ventricular (LV) function and reduced infarct size. Although pretreatment with adenosine, diazoxide or SNAP alone was capable of reducing infarct size, PPC with each drug alone or in a combination of two drugs except for diazoxide plus SNAP failed to reduce infarct size. In contrast, PPC in combination with adenosine, diazoxide and SNAP (triple combination PPC) conferred significant improvement of LV function and reduction of infarct size that was as effective as IPC.

4. Cardioprotection afforded by triple combination PPC was abolished by the Gi/o-protein inhibitor pertussis toxin, the mitochondiral KATP channel inhibitor 5-hydroxydecanoate or the nitric oxide (NO) scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl imidazoline-1-oxyl 3-oxide (carboxy-PTIO).

5. Protein kinase C (PKC)-egr in the particulate fraction was activated throughout preconditioning ischaemia and reperfusion. Although PKC-egr was activated during treatment with adenosine, diazoxide or SNAP alone, it was inactivated after washout. In contrast, PKC-egr remained activated after triple combination PPC. The PKC inhibitor chelerythrine abolished activation of PKC-egr and cardioprotection afforded by IPC and triple combination PPC.

6. These results demonstrate that combined PPC with a G-protein-coupled receptor agonist, a mitochondrial KATP channel opener and an NO donor is necessary to mimic IPC and such synergistic cardioprotection is associated with enhanced and sustained activation of PKC-egr.

Keywords: diazoxide; ischaemic preconditioning; pharmacological preconditioning; protein kinase C

Document Type: Research article

DOI: 10.1046/j.1440-1681.2003.03896.x

Affiliations: 1: Department of Thoracic and Cardiovascular Surgery, Kansai Medical University, Moriguchi City, Japan

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A